The $360 Billion Ghost Market Opportunity That Venture Capital Is Overlooking
Women’s Health VC Has Tripled Since 2019, Yet It Still Represents Just 2.3% of Healthcare Funding
Powered By The WHAM® Report
Since 2019, women’s health venture capital investment has tripled, outpacing overall healthcare growth, yet it still represents just 2.3% of healthcare VC dollars.
The Allocation Gap
That allocation gap is the opportunity. When the market is expanded to include conditions that affect women differently or disproportionately, not just exclusively, the commercial potential expands dramatically.
The Untapped Value
Including conditions that disproportionately and differently affect women reveals an estimated $360B global ghost market spanning critical areas that remain significantly undercapitalized relative to consumer demand, spanning critical areas like healthy aging, bone health, cognitive health, heart health, menopause, endometriosis, and more.
The women’s health market is expanding and is projected to grow from $45.5B in 2025 to $58B by 2029.
Accelerating Momentum
The venture capital landscape for women’s health between 2024 and 2025 shows accelerating momentum. Rapid growth alongside minimal capital allocation signals a category primed for outsized returns and a clear opportunity for investors positioned to move early.
What the Data Confirms
Women’s health venture investment is scaling rapidly across both women-exclusive and women-impacted conditions. This includes conditions that disproportionately impact women and reveals a materially larger, underrecognized investable market.
Divergence of Growth and Capital
Between 2018 and 2023, investments in women’s health grew by more than 300%, despite receiving only 2% of total healthcare VC funding during that period. The resulting gap signals a clear capital misalignment and early-mover opportunity.
